ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Gates backs Novartis infectious disease drug

by Michael McCoy
February 26, 2018 | APPEARED IN VOLUME 96, ISSUE 9

The Bill & Melinda Gates Foundation will give $6.5 million to Novartis to advance development of KDU731, a drug being developed for the treatment of cryptosporidiosis, a diarrheal disease that is one of the leading causes of childhood mortality.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment